FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Raymond Tubbs

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Procedures

Physiology

Genes & Molecular Sequences

Genes, erbB-2

Co-author Network

Publications

TOP 3
Carlo Valentino; Dennis Weisenburger; Wenjun Zhang; Andreas Rosenwald; Raymond Tubbs; Rita M Braziel; Patrick Brunhoeber; Elias Campo; Wing C Chan; James R Cook; Jan Delabie; Randy Gascoyne; Tom Grogan; Elaine Jaffe; Nathalie Johnson; Samantha Kendrick; Hiro Nitta; German Ott; Lisa M Rimsza
Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.
Pierre L Triozzi; Raymond Tubbs; Susan Achberger; Wayne Aldrich; Charles V Biscotti; Paul Elson; Arun D Singh
Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Sucheta Kulkarni; Leya Saju; Carol Farver; Raymond Tubbs
Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Raymond Tubbs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Carlo Valentino; Dennis Weisenburger; Wenjun Zhang; Andreas Rosenwald; Raymond Tubbs; Rita M Braziel; Patrick Brunhoeber; Elias Campo; Wing C Chan; James R Cook; Jan Delabie; Randy Gascoyne; Tom Grogan; Elaine Jaffe; Nathalie Johnson; Samantha Kendrick; Hiro Nitta; German Ott; Lisa M Rimsza
Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma.
American journal of clinical pathology 2013;139(2):242-54.
2013: Pierre L Triozzi; Raymond Tubbs; Susan Achberger; Wayne Aldrich; Charles V Biscotti; Paul Elson; Arun D Singh
Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
Melanoma research 2013;23(1):1-7.
2012: Sucheta Kulkarni; Leya Saju; Carol Farver; Raymond Tubbs
Calpain4 is required for activation of HER2 in breast cancer cells exposed to trastuzumab and its suppression decreases survival and enhances response.
International journal of cancer. Journal international du cancer 2012;131(10):2420-32.
2012: Mary Aronow; Charles Biscotti; Yogen Saunthararajah; Yang Sun; Pierre Triozzi; Raymond Tubbs; Arun D Singh
Monosomy 3 by FISH in uveal melanoma: variability in techniques and results.
Survey of ophthalmology 2012;57(5):463-73.
2011: Khalid Sossey-Alaoui; Raymond Tubbs; Mitali Das; Erinn Downs-Kelly; lahoucine Izem; Edward F Plow
WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade.
International journal of cancer. Journal international du cancer 2011;129(6):1331-43.
2011: Virginia Torres; Pierre L Triozzi; Charis Eng; Raymond Tubbs; Lynn Schoenfiled; John W Crabb; Yogen Saunthararajah; Arun D Singh
Circulating tumor cells in uveal melanoma.
Future oncology (London, England) 2011;7(1):101-9.
2010: Bettina G Papouchado; Jonathan Myles; Ricardo V Lloyd; Mark Stoler; Andre M Oliveira; Erinn Downs-Kelly; Adrienne Morey; Michael Bilous; Ray Nagle; Nichole L Prescott; Lin Wang; Lidija Dragovich; Abigail McElhinny; Carole Ferrell Garcia; Jim Ranger-Moore; Heather Free; William Powell; Margaret Loftus; James Pettay; Fabien Gaire; Christopher Roberts; Manfred Dietel; Patrick Roche; Thomas M Grogan; Raymond Tubbs
Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility.
The American journal of surgical pathology 2010;34(6):767-76.
2009: Ming Zhou; Ximing J Yang; Jose I Lopez; Rajal B Shah; Ondrej Hes; Steven S Shen; Rongshan Li; Yu Yang; Fan Lin; Paul Elson; Linda Sercia; Cristina Magi-Galluzzi; Raymond Tubbs
Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
The American journal of surgical pathology 2009;33(12):1840-9.
2009: Raymond Tubbs; William E Barlow; G Thomas Budd; Eric Swain; Peggy Porter; Allen Gown; I-Tien Yeh; George Sledge; Charles Shapiro; James Ingle; Charles Haskell; Kathy S Albain; Robert Livingston; Daniel F Hayes
Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3881-6.
2009: Arun D Singh; Raymond Tubbs; Charles V Biscotti; Lynn Schoenfield; Pierre Trizzoi
Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma.
Archives of pathology & laboratory medicine 2009;133(8):1223-7.
2005: Raymond Tubbs; James Pettay; Richard Powell; David G Hicks; Patrick Roche; William Powell; Thomas M Grogan; James F Hainfeld
High-resolution immunophenotyping of subcellular compartments in tissue microarrays by enzyme metallography.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2005;13(4):371-5.
2005: Erinn Downs-Kelly; James Pettay; David Hicks; Marek Skacel; Brian Yoder; Lisa Rybicki; Jonathan Myles; Joseph Sreenan; Patrick Roche; Richard Powell; James F Hainfeld; Thomas M Grogan; Raymond Tubbs
Analytical validation and interobserver reproducibility of EnzMet GenePro: a second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast.
The American journal of surgical pathology 2005;29(11):1505-11.
2005: Ramtin Agah; Stephen Ellis; Sue Chase; Mark Henderson; Lisa Mlady; Gurunathan Murugesan; Raymond Tubbs; Kandice Marchant; Ilka Warshawsky; Colleen Rouse; Kathy Hughes; Patricia Welch; Eric J Topol
Creation of a large-scale genetic data bank for cardiovascular association studies.
American heart journal 2005;150(3):500-6.
2005: Gurunathan Murugesan; Kandice Kottke-Marchant; Stephen Ellis; Ramtin Agah; Raymond Tubbs
LightTyper platform for high-throughput clinical genotyping.
Expert review of molecular diagnostics 2005;5(3):457-71.
2005: Lin Lin; David Hicks; Bo Xu; Jessica E Sigel; Wilma F Bergfeld; Elizabeth Montgomery; Cyril Fisher; Marybeth Hartke; Raymond Tubbs; John R Goldblum
Expression profile and molecular genetic regulation of cyclin D1 expression in epithelioid sarcoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2005;18(5):705-9.
2004: David G Hicks; Gabe Longoria; James Pettay; Thomas M Grogan; Shannon Tarr; Raymond Tubbs
In situ hybridization in the pathology laboratory: general principles, automation, and emerging research applications for tissue-based studies of gene expression.
Journal of molecular histology 2004;35(6):595-601.
2004: Raymond Tubbs; James Pettay; David Hicks; Marek Skacel; Richard Powell; Thomas M Grogan; James F Hainfeld
Novel bright field molecular morphology methods for detection of HER2 gene amplification.
Journal of molecular histology 2004;35(6):589-94.
2003: Tarek Mekhail; Rika Kawanishi-Tabata; Raymond Tubbs; Andrew C Novick; Paul Elson; Ram Ganapathi; Mahrukh K Ganapathi; Ronald Bukowski
Renal cell carcinoma (RCC) and telomerase activity: relationship to stage.
Urologic oncology 2003;21(6):424-30.
2003: Preetha Ramalingam; Wei-Sing Chu; Raymond Tubbs; Lisa Rybicki; James Pettay; Eric D Hsi
Latent membrane protein 1, tumor necrosis factor receptor-associated factor (TRAF) 1, TRAF-2, TRAF-3, and nuclear factor kappa B expression in posttransplantation lymphoproliferative disorders.
Archives of pathology & laboratory medicine 2003;127(10):1335-9.
2003: Irum Rishi; Hasna Baidouri; Jamil A Abbasi; Rebecca Bullard-Dillard; Andre A. Kajdacsy-Balla; Joseph P Pestaner; Marek Skacel; Raymond Tubbs; Omar Bagasra
Prostate cancer in African American men is associated with downregulation of zinc transporters.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2003;11(3):253-60.
2002: Rika Kawanishi-Tabata; Francisco Lopez; Sam Fratantonio; Nam Kim; John R Goldblum; Raymond Tubbs; Paul Elson; Ian C Lavery; Ronald M Bukowski; Ram Ganapathi; Mahrukh K Ganapathi
Telomerase activity in stage II colorectal carcinoma.
Cancer 2002;95(9):1834-9.
2002: Raymond Tubbs; Marek Skacel; James Pettay; Richard Powell; Jonathan Myles; David Hicks; Joseph Sreenan; Patrick Roche; Mark Stoler; James F Hainfeld
Interobserver interpretative reproducibility of GOLDFISH, a first generation gold-facilitated autometallographic bright field in situ hybridization assay for HER-2/neu amplification in invasive mammary carcinoma.
The American journal of surgical pathology 2002;26(7):908-13.
2002: Raymond Tubbs; James Pettay; Marek Skacel; Richard Powell; Mark Stoler; Patrick Roche; James F Hainfeld
Gold-facilitated in situ hybridization: a bright-field autometallographic alternative to fluorescence in situ hybridization for detection of Her-2/neu gene amplification.
The American journal of pathology 2002;160(5):1589-95.
2000: Carol Farver; Baisakhi Raychaudhuri; Anagha Malur; Judith A Drazba; J Maurer; Raymond Tubbs; Atul C Mehta; Robert J Schilz; Mary Jane Thomassen
Increased alveolar macrophage nuclear factor-kappa B activation and macrophage inhibitory protein-1alpha levels in lung transplant patients.
Transplantation 2000;70(11):1599-603.
2000: Thomas Olencki; James Finke; Raymond Tubbs; Paul Elson; D McLain; P Herzog; G Thomas Budd; H Gunn; Ronald M Bukowski
Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effects.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(5):549-56.
1999: Ronald M Bukowski; Patricia Rayman; Luis Molto; Charles S Tannenbaum; Thomas Olencki; David M Peereboom; Raymond Tubbs; D McLain; G Thomas Budd; T Griffin; Andrew C Novick; Thomas Hamilton; James Finke
Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2780-9.
1999: Robert G Uzzo; Patricia Rayman; Vladimir Kolenko; PE Clark; T Bloom; AM Ward; Luis Molto; Charles S Tannenbaum; L J Worford; Ronald Bukowski; Raymond Tubbs; Eric D Hsi; NH Bander; Andrew C Novick; James H Finke
Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1219-29.
1999: Vladimir Kolenko; Patricia Rayman; B Roy; Martha K Cathcart; John O'Shea; Raymond Tubbs; Lisa Rybicki; Ronald Bukowski; James Finke
Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.
Blood 1999;93(7):2308-18.
1999: James Ulchaker; J Panuto; Patricia Rayman; Andrew C Novick; Paul Elson; Raymond Tubbs; James H Finke; Ronald M Bukowski
Interferon-gamma production by T lymphocytes from renal cell carcinoma patients: evidence of impaired secretion in response to interleukin-12.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1999;22(1):71-9.
1998: Christine E Campbell; N P Kuriyan; R R Rackley; M J Caulfield; Raymond Tubbs; J Finke; Bryan R G Williams
Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma.
International journal of cancer. Journal international du cancer 1998;78(2):182-8.
1998: W Ling; Patricia Rayman; Robert G Uzzo; P Clark; H J Kim; Raymond Tubbs; Andrew C Novick; Ronald Bukowski; T Hamilton; James Finke
Impaired activation of NFkappaB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IkappaBalpha.
Blood 1998;92(4):1334-41.
1998: Charles S Tannenbaum; Raymond Tubbs; D Armstrong; James H Finke; Ronald M Bukowski; Thomas Hamilton
The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(2):927-32.
1997: SJ Plummer; M J Paris; Jonathan Myles; Raymond Tubbs; Joseph Crowe; Graham Casey
Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
Genes, chromosomes & cancer 1997;20(4):354-62.
1997: Vladimir Kolenko; Q Wang; M C Riedy; John O'Shea; Jerome Ritz; Martha K Cathcart; Patricia Rayman; Raymond Tubbs; MG Edinger; Andrew C Novick; Ronald Bukowski; James Finke
Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):3057-67.
1997: Ronald M Bukowski; Thomas Olencki; Q Wang; David M Peereboom; G Thomas Budd; Paul Elson; Kate Wakeling; L Tuason; Patricia Rayman; Raymond Tubbs; D McLain; E Klein; Andrew C Novick; James Finke
Phase II trial of interleukin-2 and interferon-alpha in patients with renal cell carcinoma: clinical results and immunologic correlates of response.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(4):301-11.
1997: I Zehbe; Gerhard W Hacker; H Su; Cornelia Hauser-Kronberger; James F Hainfeld; Raymond Tubbs
Sensitive in situ hybridization with catalyzed reporter deposition, streptavidin-Nanogold, and silver acetate autometallography: detection of single-copy human papillomavirus.
The American journal of pathology 1997;150(5):1553-61.
1996: Stuart M Flechner; S R Inman; Nicholas T Stowe; S Kabbani; Raymond Tubbs; Andrew C Novick
Videomicroscopic analysis of the renal microcirculation during xenograft hyperacute rejection in the rat.
Transplantation proceedings 1996;28(2):713-4.
1996: Ronald M Bukowski; Thomas Olencki; H Gunn; D McLain; G Thomas Budd; Kate Wakeling; L Tuason; C Redovan; Patricia Rayman; Raymond Tubbs; D Resta; Paul Elson; James Finke
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(2):347-57.
1996: F Steinbach; Kazunari Tanabe; J Alexander; M Edinger; Raymond Tubbs; W Brenner; M Stöckle; Andrew C Novick; Eric A Klein
The influence of cytokines on the adhesion of renal cancer cells to endothelium.
The Journal of urology 1996;155(2):743-8.
1996: Charles S Tannenbaum; N Wicker; D Armstrong; Raymond Tubbs; James Finke; Ronald M Bukowski; Thomas Hamilton
Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(2):693-9.
1996: Thomas Olencki; James Finke; Raymond Tubbs; L Tuason; T Greene; D McLain; S J Swanson; P Herzog; J Stanley; M Edinger; G Thomas Budd; Ronald M Bukowski
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(1):69-80.
1996: J Sibal; Rafael Valenzuela; Raymond Tubbs; E Hodge; J Nally
Successful renal transplantation in a patient with large granular lymphocytic leukemia with natural killer cell proliferation.
Nephron 1996;72(2):292-7.
1995: P Karnik; S Plummer; Graham Casey; J Myles; Raymond Tubbs; J Crowe; Bryan R G Williams
Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis.
Human molecular genetics 1995;4(10):1889-94.
1995: Q Wang; J Stanley; S Kudoh; J Myles; Vladimir Kolenko; T Yi; Raymond Tubbs; Ronald Bukowski; James Finke
T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(3):1382-92.
1995: Q Wang; C Redovan; Raymond Tubbs; Thomas Olencki; E Klein; S Kudoh; James Finke; Ronald M Bukowski
Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes.
International journal of cancer. Journal international du cancer 1995;61(6):780-5.
1994: X Li; James Liu; J K Park; Thomas Hamilton; Patricia Rayman; E Klein; M Edinger; Raymond Tubbs; Ronald Bukowski; James Finke
T cells from renal cell carcinoma patients exhibit an abnormal pattern of kappa B-specific DNA-binding activity: a preliminary report.
Cancer research 1994;54(20):5424-9.
1994: Ronald M Bukowski; S A Murthy; James Finke; M J Caulfield; Raymond Tubbs; P Herzog; J Stanley; M Edinger; L Tuason; D McLain
Phase I trial of cisplatin, WR-2721, and the murine monoclonal antibody R24 in patients with metastatic melanoma: clinical and biologic effects.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;15(4):273-82.
1993: Ronald M Bukowski; S Murthy; D McLain; James Finke; Steven Andresen; Raymond Tubbs; L Bauer; V Gibson; G Thomas Budd; Mary Jane Thomassen
Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: clinical and immunologic effects.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1993;13(4):267-74.
1993: J Diaz; Raymond Tubbs; M Stoler; Thomas M Grogan
Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. SWOG Central Repository Members.
Leukemia & lymphoma 1993;9(1-2):91-4.
1992: J Diaz; G Segal; Raymond Tubbs; M Stoler; Thomas M Grogan
Determination of T cell monoclonality in non-Hodgkin's lymphoma by frozen section immunohistology. The SWOG Central Repository Members.
Leukemia & lymphoma 1992;8(6):477-81.
1991: Ronald M Bukowski; J S Sergi; G Thomas Budd; S Murthy; Raymond Tubbs; V Gibson; L Bauer; J Stanley; S Gautam; James Finke
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignancies.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(6):432-9.
1991: Ronald M Bukowski; WILLIAM SHARFMAN; S Murthy; Patricia Rayman; Raymond Tubbs; J Alexander; G Thomas Budd; J S Sergi; L Bauer; V Gibson
Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.
Cancer research 1991;51(16):4199-205.
1990: Ronald M Bukowski; S Murthy; J Sergi; G Thomas Budd; S McKeever; S V Medendorp; Raymond Tubbs; V Gibson; James Finke
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.
Journal of biological response modifiers 1990;9(6):538-45.
1990: M J Caulfield; Barbara P Barna; S Murthy; Raymond Tubbs; J Sergi; S Medendorp; Ronald M Bukowski
Phase Ia-Ib trial of an anti-GD3 monoclonal antibody in combination with interferon-alpha in patients with malignant melanoma.
Journal of biological response modifiers 1990;9(3):319-28.
1990: N F Chikkala; I Lewis; J Ulchaker; J Stanley; Raymond Tubbs; James H Finke
Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level.
Cancer research 1990;50(4):1176-82.
1990: A J Fishleder; James H Finke; Raymond Tubbs; Ronald M Bukowski
Induction by interleukin-2 of oligoclonal expansion of cultured tumor-infiltrating lymphocytes.
Journal of the National Cancer Institute 1990;82(2):124-8.
1990: J Alexander; Patricia Rayman; M Edinger; R Connelly; Raymond Tubbs; Ronald Bukowski; Edson J Pontes; James Finke
TIL from renal-cell carcinoma: restimulation with tumor influences proliferation and cytolytic activity.
International journal of cancer. Journal international du cancer 1990;45(1):119-24.
1990: J Edson Pontes; E Pescatori; R Connelly; T Hashimura; Raymond Tubbs
Circulating cancer cells in renal-cell carcinoma.
Progress in clinical and biological research 1990;348():1-12.
1989: G Thomas Budd; B Osgood; Barbara P Barna; J M Boyett; James Finke; S V Medendorp; S Murthy; C Novak; J Sergi; Raymond Tubbs
Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects.
Cancer research 1989;49(22):6432-6.
1989: Leonard H Calabrese; M Estes; Belinda Yen-Lieberman; M R Proffitt; Raymond Tubbs; A J Fishleder; Kerry H Levin
Systemic vasculitis in association with human immunodeficiency virus infection.
Arthritis and rheumatism 1989;32(5):569-76.
1989: M M Ziegelbaum; James H Finke; Raymond Tubbs; James E Montie; J Edson Pontes; I Lewis
In vitro activation of lymphocytes by interleukin 2 in patients with renal cell carcinoma.
Urology 1989;33(2):106-9.
1988: James H Finke; Raymond Tubbs; B Connelly; Edson J Pontes; James E Montie
Tumor-infiltrating lymphocytes in patients with renal-cell carcinoma.
Annals of the New York Academy of Sciences 1988;532():387-94.